Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Clinics and Research in Hepatology and Gastroenterology|June 30, 2020
Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohortAnais Vallet-Pichard, Jean-Michel Correas, Celine Dorival, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
Med (New York, N.Y.)|October 14, 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas surveyBenjamin Terrier, Fabrice Carrat, Evguenia Krastinova, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2021
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitisPierre-Antoine Soret, Laurent Lam, Fabrice Carrat, et al.
Autoimmunity Reviews|July 15, 2017
Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patientsArsene Mekinian, Guillaume Dervin, Nathanael Lapidus, et al.
Viruses|May 28, 2022
Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in FranceDorine Decarreaux, Marie Pouquet, Cecile Souty, et al.
Scientific Reports|March 5, 2024
SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 waveMarie Pouquet, Dorine Decarreaux, Laura Di Domenico, et al.
BMC Infectious Diseases|April 4, 2019
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohortAnne Laurain, Sophie Metivier, Georges Haour, et al.
International Journal of Epidemiology|July 22, 2021
Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort studyFabrice Carrat, Xavier de Lamballerie, Delphine Rahib, et al.
Pageof 28